Louisiana accused pharmaceutical giant CVS of using its dominant market position to abuse customer information, drive up drug ...

An Iowa business group has joined up with some health insurance plans and employers in the state to challenge a new local law ...

It's just over a week since pharmacy benefit managers CVS and Express Scripts sued the state of Arkansas over a new monopoly-busting law prohibiting PBMs—middle ...

The law was likely intended to check the influence of the three largest PBMs — CVS Caremark, Express Scripts and Optum Rx — ...

CVS and Express Scripts asked a federal judge on Thursday to block a law prohibiting pharmacy benefit managers from owning or operating pharmacies in Arkansas, challenging the first such restriction ...

Express Scripts, like other major PBMs, has also made recent changes to its products the company says will make its business practices more transparent and accountable to its clients.

Dive Insight: Kroger notified Express Scripts in 2022 that it planned to terminate their pharmacy provider agreement for commercial customers after “dozens” of attempts to negotiate a “more ...

Coleman’s lawsuit follows one filed by Arkansas, which in July sued Express Scripts and Optum, alleging PBMs contributed to the dramatic rise in the abuse of painkillers. Kentucky’s lawsuit ...

Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action ST. LOUIS, Sept. 20, 2024 /PRNewswire ...

For more than two years, Express Scripts fully cooperated with the FTC study into the PBM industry, meeting the agency's extensive demands for data and information. The FTC's report disregarded ...

Express Scripts has filed suit against the Federal Trade Commission (FTC), demanding that the agency retract a damning report on the pharmacy benefit management industry. In the lawsuit, which was ...

Express Scripts, a subsidiary of The Cigna Group, has filed a lawsuit against the Federal Trade Commission (FTC), demanding a retraction of a July 2024 report it claims is false, misleading, and ...